Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For AMZ.DE
Valuation Weak
14%
Profitability n.A.
Fin. Growth Bad
0%
Leverage & Liquidity Weak
33%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 2.58 1.07 1.05
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 0.14 2.23 2.23
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 6.94 20.85 19.49
Cash -2.31 8.19 8.38
Capex -1.95 -1.44 -1.41
Free Cash Flow -85.47 0.39 2.69
Revenue -15.98 13.79 16.41
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 13.18 0.19 0.17
Operating Margin 37.43 0.11 0.08
ROA -2.39 0.02 0.02
ROE -8.52 0.05 0.05
ROIC 16.18 0.03 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of AMZ.DE is permitted for members.
5 Growth
The "Growth Entry" for the Focus of AMZ.DE is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of AMZ.DE is permitted for members.